CNS PHARMACEUTICALS INC - COM (CNSP)

CUSIP: 18978H102

Q2 2020 13F Holders as of 30 Jun 2020

Share change
-9,936
SEC-reported price per share
$2.15
Number of holders
5
Value change
-$19,739
Number of buys
1
Number of sells
5

Security key

18978H102

Report period

Q2 2020

Institutions

5

Top holders

5

Ownership snapshot

Top reported holders of CNSP - CNS PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ESSEX INVESTMENT MANAGEME...
Disclosed value leader
ESSEX INVESTMENT MANAGEME...
Comparable rows
0/8
Latest evidence
31 Mar 2020
13F Highest disclosed value: $150,000 8 rows are not safely comparable across share classes. Showing 1-6 of 8 holder rows.

Quick read

ESSEX INVESTMENT MANAGEMENT CO LLC has the largest disclosed position value at $150K.

0 of 8 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ESSEX INVESTMENT MANAGEMENT CO LLC's linked filing trail.
Disclosed position value Top 5
ESSEX INVESTMENT MANAGEMENT CO LLC $150K
Integrated Advisors Network LLC $22K
Alpha Cubed Investments, LLC $21K
BlackRock Finance, Inc. $11K
MORGAN STANLEY $4K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 8 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ESSEX INVESTMENT MANAGEMENT CO LLC
13F
Company
13F
—
denominator unverified
$150,000
71,494 shares
— 31 Mar 2020
Integrated Advisors Network LLC
13F
Company
13F
—
denominator unverified
$22,000
10,700 shares
— 31 Mar 2020
Alpha Cubed Investments, LLC
13F
Company
13F
—
denominator unverified
$21,000
10,000 shares
— 31 Mar 2020
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$11,000
5,397 shares
— 31 Mar 2020
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$4,000
2,035 shares
— 31 Mar 2020
UBS Group AG
13F
Company
13F
—
denominator unverified
$4,000
1,930 shares
— 31 Mar 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
5
Shares
92,958
Rows available
5
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders
7
Q2 2020 holders
5
Holder diff
-2
Investor Q1 2020 Shares Q2 2020 Shares Share Diff Share Chg % Q1 2020 value Q2 2020 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .